Tyra Biosciences, Inc. (TYRA) stock plummeted 6.58% during intraday trading on Thursday, reflecting significant selling pressure.
The sharp decline appears to be driven by analyst commentary on the company. Analysts recently provided insights on Tyra Biosciences, and the market reaction suggests the assessment may have included downgrades or concerns about the company's prospects, leading to investor pessimism.